SKIN vs DXCM
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
SKIN
DXCM
Investment Advisor Scores
DXCM
AI Analyst Insights
Detailed Metrics Comparison
| Metric | SKIN | DXCM | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 106.383 | 28.2486 | DXCM |
| PEG Ratio | 0.9262 | 1.3487 | SKIN |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -7.8% | 13.1% | DXCM |
| Earnings Growth | 0.0% | 43.6% | DXCM |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 31.4/100 | 45.5/100 | DXCM |
| Profit Margin | -9.8% | 20.1% | DXCM |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
SKIN
MarkupPrice above SMA50, rising 50-day trend (239.2% over 20 days), RSI 81
DXCM
NeutralMixed signals - no dominant trend phase, RSI 32
Fundamentals Snapshot
| Metric | SKIN | DXCM |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 2.9 | 25.0 |
| Trailing P/E | — | 31.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.1% |
| Gross Margin | 0.7% | 0.6% |
| Operating Margin | 0.0% | 0.2% |
| EPS | -4.70 | 2.46 |
| Dividend Yield | — | — |